Skip to main content
. Author manuscript; available in PMC: 2015 Jun 16.
Published in final edited form as: Pediatr Nephrol. 2009 Jul 15;25(2):213–220. doi: 10.1007/s00467-009-1252-4

Fig 3.

Fig 3

Pre- and post-transplant FGF-23 (a) and PTH (b) concentrations in subjects with and without severe hypophosphatemia (<1.5 mg/dl). The relative risk of severe hypophosphatemia was stronger with FGF-23 (5.3, p=0.02) than with PTH (0.2, p=0.01) when compared to those falling below the corresponding median levels. Reprinted with permission by Bhan et al. [48]